Leadership Transition at Monash IVF Group

Monash IVF Group Limited (ASX: MVF) announced the resignation of CEO and Managing Director Michael Knaap, effective 12 June 2025. Mr. Knaap, who joined the company in 2019, played a key role in steering the organization through a transformative growth period. The Board expressed its appreciation for his dedication and leadership. In response, the company appointed Malik Jainudeen, current Chief Financial Officer and Company Secretary, as Acting CEO. Mr. Jainudeen, a Monash IVF veteran since 2014, brings substantial institutional knowledge and financial expertise, backed by a decade at KPMG auditing ASX-listed firms. His appointment aims to ensure stability and continuity during the transition. His remuneration will remain as detailed in the 2024 Annual Report until further notice

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com